Toggle light / dark theme

Ira Pastor, ideaXme longevity and aging ambassador and founder of Bioquark interviews Luba Greenwood J.D., Strategic Business Development and Corporate Ventures, Verily (Google Life Sciences), Board Member Mass Bio and Brooklyn ImmunoTherapeutics LLC.

Note: Following this interview, Verily announced a major set of collaborations with big pharma companies, further executing on its strategy in healthcare. Breaking news: https://www.cnbc.com/2019/05/20/alphabet-verily-doing-clinic…T4eLzIucEI

Ira Pastor comments:

In 2019 we have surpassed $7 trillion in total annual healthcare expenditures around the globe. As part of that $7 trillion, we’re now spending close to a $1 trillion a year on pharmaceutical products, $350 billion on medical devices, $200 billion on new Life Sciences R&D. Equally fascinating to note are the names of organizations becoming involved in this space in 2019.

‘It’s not always convenient for people to leave their homes to retrieve deliveries or for businesses to run their own delivery services,’ Ken Washington, chief technology officer at Ford, wrote in a blog post.

‘If we can free people up to focus less on the logistics of making deliveries, they can turn their time and effort to things that really need their attention.

‘Enter Digit, a two-legged robot designed and built by Agility Robotics to not only approximate the look of a human, but to walk like one, too,’ Washington added.

Read more

Quantum computing’s processing power could begin to improve artificial-intelligence systems within about five years, experts and business leaders said.

For example, a quantum computer could develop AI-based digital assistants with true contextual awareness and the ability to fully understand interactions with customers, said Peter Chapman, chief executive of quantum-computing startup IonQ Inc.

“Today, people are frustrated when a digital assistant says, ‘Sorry, I couldn’t understand that,’” said Mr. Chapman, who was named CEO of the venture-capital-backed startup this week after about five years as director of engineering for Amazon.com Inc.’s Amazon Prime. Quantum computers “could alleviate those problems,” he said.

Read more

Some consumers place importance on locally grown or organic food. Others want the products they purchase to look and taste good. Yet others focus on low prices. However, no matter what their other requirements, everyone would like their food to be free of contaminants, which makes it quite worrying that over 97 percent of European food products contain pesticide residues. The problem is that current contamination testing processes can be long and expensive, and can only be conducted by specialist personnel.

A new device developed by the INSPECTO project team may now offer an affordable, fast and reliable solution to this problem. Coordinated by Inspecto Solutions Ltd, the EU-funded project has introduced a portable device that identifies in real time chemical contamination in food.

The scanner device can detect chemicals at specified by regulatory authorities. It also makes it possible for businesses to tailor their testing to their needs, scanning for specific sets of liquid or solid contaminants. Being able to conduct multiple scans in one day means they don’t have to wait for results. What’s more, the person operating the device doesn’t have to be a skilled chemist or technician, meaning that expensive and lengthy lab tests are eliminated. Farmers are able to measure pesticide residue levels on their crops and food producers can check for contaminants when purchasing produce. Additionally, supermarkets can conduct tests before distributing fruits and vegetables and quality assurers can enforce contaminant policies in the field.

Read more

Global Organs-on-chips Market Size, Status and Forecast 2019–2025

The report provides insightful details – how clients enhance their basic leadership capacity within the worldwide Organs-on-chips Market business. Utilizing figures and flowcharts are brief in this report, the specialists represented to the analyzed information in a superior acceptable manner. This report identifies that rapidly changing market trends and competitive landscape with growth significant CAGR during Forecast. Along, with latest marketing factors those are essential to monitor market performance and crucial decisions for progress and profitability.

According to this study, the next Y-o-Y (year over year) Organs-on-chips market will register a XX% CAGR in terms of revenue, the Astonishing Growth market size will reach US$ XX million by 2025, from US$ XX million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in the Market New Research Study.

Read more

May is almost over, so it’s time to check in with the Ending Age-Released Diseases conference and see how things are developing with the event.

If you’re unfamiliar with us, we’re hosting our second annual conference at the Cooper Union in New York City on July 11-12th this year. It will feature some of the leading names in both aging research and biotech business and investment coming together to share their knowledge and insights with the audience.

Aging research is on the cusp of some major breakthroughs in the battle against age-related diseases, and we invite you to join us for an action-packed event filled with exciting talks and discussion panels featuring some of the leaders of aging research and the biotech business.

Read more

Nearly 50 years ago, The New York Times—widely considered America’s paper of record—changed the media industry by creating the first modern Op-Ed page. Since then, their Opinion section has arguably become the most important voice for many public ideas that enter and change the world. Everyone from Heads of State to the globe’s most powerful business people to Nobel Prize winners to everyday citizens have written there when they had something essential to say about the times we live in. I’m super excited to share my first Op-Ed for The New York Times on #biohacking and the growing concern of legalizing implants. It’s a happy professional day for me, and an important step forward for the growing #transhumanism movement as we begin to enter mainstream culture.


Implant technology can change the world — unless politicians give in to the hysteria against it.

Read more